Aditxt Inc. (ADTX) - Total Assets
Based on the latest financial reports, Aditxt Inc. (ADTX) holds total assets worth $13.91 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Aditxt Inc. (ADTX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Aditxt Inc. - Total Assets Trend (2017–2025)
This chart illustrates how Aditxt Inc. 's total assets have evolved over time, based on quarterly financial data. Explore Aditxt Inc. long-term investment allocation to see how much of total assets are deployed in long-term investments.
Aditxt Inc. - Asset Composition Analysis
Current Asset Composition (December 2025)
Aditxt Inc. 's total assets of $13.91 Million consist of 23.1% current assets and 76.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 19365.8% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $5.77 Million | 35.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.78 Million | 16.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Aditxt Inc. 's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Aditxt Inc. (ADTX) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aditxt Inc. 's current assets represent 23.1% of total assets in 2025, a decrease from 100.0% in 2017.
- Cash Position: Cash and equivalents constituted 19365.8% of total assets in 2025, up from 100.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 35.0% of total assets.
Aditxt Inc. Competitors by Total Assets
Key competitors of Aditxt Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $8.59 Billion |
|
Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC
|
USA | $4.40K |
|
Krystal Biotech Inc
NASDAQ:KRYS
|
USA | $1.40 Billion |
|
Verona Pharma PLC ADR
NASDAQ:VRNA
|
USA | $572.87 Million |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
|
USA | $641.76 Million |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
Hebei Changshan Biochem Pharma
SHE:300255
|
China | CN¥4.66 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF2.64 Billion |
Aditxt Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.06 | 0.08 | 1.90 |
| Quick Ratio | 0.05 | 0.08 | 1.90 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-12.49 Million | $-13.96 Million | $4.70 Million |
Aditxt Inc. - Advanced Valuation Insights
This section examines the relationship between Aditxt Inc. 's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.05 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -48.6% |
| Total Assets | $16.52 Million |
| Market Capitalization | $3.59K USD |
Valuation Analysis
Below Book Valuation: The market values Aditxt Inc. 's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Aditxt Inc. 's assets decreased by 48.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Aditxt Inc. (2017–2025)
The table below shows the annual total assets of Aditxt Inc. from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $16.52 Million | -48.62% |
| 2024-12-31 | $32.14 Million | -27.89% |
| 2023-12-31 | $44.58 Million | +315.25% |
| 2022-12-31 | $10.74 Million | -35.58% |
| 2021-12-31 | $16.66 Million | +27.24% |
| 2020-12-31 | $13.10 Million | +10501.71% |
| 2019-12-31 | $123.53K | +6.76% |
| 2018-12-31 | $115.71K | +362.84% |
| 2017-12-31 | $25.00K | -- |
About Aditxt Inc.
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body nat… Read more